NCT02343302

Brief Summary

A very common complication following distal pancreatectomy is leakage from the pancreas, or what is called a pancreatic fistula. We hypothesize that operative drains which create suction may contribute to the development of leakage from the pancreas. This study evaluates the effect of using non-suctioning drains to prevent the development of this complication.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 15, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 21, 2015

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2021

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2021

Completed
10 months until next milestone

Results Posted

Study results publicly available

December 21, 2021

Completed
Last Updated

December 21, 2021

Status Verified

March 1, 2021

Enrollment Period

8 years

First QC Date

January 15, 2015

Results QC Date

November 22, 2021

Last Update Submit

November 22, 2021

Conditions

Keywords

Pancreatic Fistula

Outcome Measures

Primary Outcomes (1)

  • Post-operative Pancreatic Fistula

    The primary endpoint of the study is the developement of post-operative pancreatic fistula, as defined by the International Study Group of Pancreatic Surgery.

    90 days

Secondary Outcomes (1)

  • Morbidity

    90 days

Study Arms (2)

Soft Pancreatic Gland

OTHER

This arm will be patients with glands felt to have a soft texture during surgery. This arm will receive either a suction drain or a gravity drain based on the note inside the sealed envelope.

Device: Jackson-Pratt DrainDevice: Non-suctioning drainage

Hard Pancreatic Gland

OTHER

This arm will include patients felt to have a hard gland tecture at the time of surgery. This arm will receive either a suction drain or a gravity drain based on the note inside the sealed envelope.

Device: Jackson-Pratt DrainDevice: Non-suctioning drainage

Interventions

A closed suctioning drain will be placed at the time of surgery. Patients in both arm A and arm B will receive this intervention. The patients that receive this treatment will be the ones whose envelope, selected on the basis of the texture of the gland, contains a card labelled "suction drain"

Hard Pancreatic GlandSoft Pancreatic Gland

A closed non-suctioning drain will be placed at the time of surgery. Patients in both arm A and arm B will receive this intervention. The patients that receive this treatment will be the ones whose envelope, selected on the basis of the texture of the gland, contains a card labelled "gravity drain"

Hard Pancreatic GlandSoft Pancreatic Gland

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing distal pancreatectomy at Johns Hopkins Hospital

You may not qualify if:

  • Children \<18 years old, pregnant women, adults lacking capacity to consent, non-english speakers, and prisoners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

Pancreatic Fistula

Condition Hierarchy (Ancestors)

Digestive System FistulaDigestive System DiseasesPancreatic DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Director of Clinical Trials
Organization
Johns Hopkins University

Study Officials

  • Christopher L Wolfgang, MD PHD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2015

First Posted

January 21, 2015

Study Start

February 1, 2013

Primary Completion

February 15, 2021

Study Completion

February 20, 2021

Last Updated

December 21, 2021

Results First Posted

December 21, 2021

Record last verified: 2021-03

Locations